Ingersoll Rand reaffirms commitment, investments in India
Optimistic that local manufacturing will also help ensure faster delivery and deployment time alongside better cost benefits across the pharma sector
Industrial talks | 14/11/2022 | By Sudeep Soparkar | 791
JB Pharma commits to ESG in its maiden Sustainability Report
The sustainability report is for the year FY 2021 – 2022
Industrial talks | 17/10/2022 | By Sudeep Soparkar | 615
Cipla's OSD plant bags Global Lighthouse Network recognition
Cipla deployed 'Digital Automation Analytics' (DAA) across a network of 22 India sites in parallel to unlock end-to-end costs, productivity and quality leadership
Industrial talks | 12/10/2022 | By Sudeep Soparkar | 1857
Lupin appoints Shahin Fesharaki as Global Chief Scientific Officer
Fesharaki will be in charge of Lupin's global R&D operations spanning branded, generic, and speciality products
Industrial talks | 07/10/2022 | By Sudeep Soparkar | 988
Supriya Lifescience appoints Rajeev Kumar Jain as CEO
He has over 35+ years of rich functional experience in the manufacturing domain of bulk drugs, intermediate and API
Industrial talks | 03/10/2022 | By Sudeep Soparkar | 1188
Piramal Pharma appoints Vibha Paul Rishi to its Board of Directors
Rishi is a marketing professional and has held global leadership positions across branding, strategy, innovation and human capital
Industrial talks | 30/09/2022 | By Sudeep Soparkar | 1206
Jiuzhou Pharma to buy Sandoz finished drugs plant in Zhongshan for $15.1 M
The Chinese firm also plans to refurbish and expand the facility, altogether redirecting $18.5 million of capital to the Sandoz project.<br />
Industrial talks | 29/09/2022 | By Sudeep Soparkar | 1100
Biopharmaceutical company Ipsen unveils 52 M Euro expansion plan
The investment is aimed at boosting medicine and ingredient production in cancer and rare disease space
Industrial talks | 28/09/2022 | By Sudeep Soparkar | 885
OPPI appoints Suresh Pattathil as president
Suresh Pattathil succeeds S Sridhar who has been the President of OPPI since February 2021
Industrial talks | 27/09/2022 | By Sudeep Soparkar | 915
Sekhmet Pharmaventures buys stake in Hyd-based Optimus Group
Optimus, a manufacturer of pharmaceutical goods with vertical integration that includes advanced intermediates, active pharmaceutical ingredients etc
Industrial talks | 27/09/2022 | By Sudeep Soparkar | 2382
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy